Extell Development Company Announces New Executive Appointments
Andrew Chung Named President and Co-CEO; Kevin D. Kim Named Executive Vice President NEW YORK, April 8, 2026 /PRNewswire/ -- Extell Development Company, one of the nation's premier real estate development firms, announced today two executive...
Singlomics Announces First Patient Dosed in Phase I Clinical Trial of DXP-106 (IL-1RAP mAb) in China
BEIJING, April 7, 2026 /PRNewswire/ -- Singlomics Biopharmaceuticals, an innovative clinical-stage biopharmaceutical company focused on the discovery and development of antibody therapeutics for oncology, inflammation, and autoimmune diseases, today...
Skoll Foundation Announces Winners of the 2026 Skoll Award for Social Innovation
With innovative solutions to some of the world's most urgent challenges, three social entrepreneurs are building a better future for all WASHINGTON, April 7, 2026 /PRNewswire/ -- Today, the Skoll Foundation announced the three organizations that...
PartnerOne Announces Chief Executive Officer to Lead Mortgage Cadence
RIVERSIDE, Calif., April 7, 2026 /PRNewswire/ -- PartnerOne, one of the fastest-growing software groups in the world, has appointed Michael Detwiler as the new Chief Executive Officer for Mortgage Cadence. PartnerOne recently acquired Mortgage...
Billion Dollar Texas Real Estate Holding Announces AMASÉ- (ah-ma-Say)
Exclusive Luxury Rental Portfolio Launches Across Premier Global Destinations. Family Office Appoints Dallas-Based Icon Global to Lead International Marketing Campaign DALLAS, April 7, 2026 /PRNewswire/ -- Amase is a privately owned collection of...
Ascletis Announces Fixed-Dose Combination of ASC30, Once-Daily Oral Small Molecule GLP-1R Agonist, and ASC39, Once-Daily Oral Small Molecule Amylin-Selective Amylin Receptor Agonist, for Clinical Development
-Fixed - dose combination of ASC30 and ASC39 (ASC30_39 FDC) tablets, dosed orally in dogs, demonstrated comparable pharmacokinetics to those observed in their respective monotherapies in a head-to-head study . The fixed dose combination had...
Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 4.803 Million Tokens, and Total Crypto and Total Cash Holdings of $11.4 Billion
Bitmine has been approved for uplisting to the New York Stock Exchange ("NYSE") from the NYSE American effective at the opening of trading on April 9, 2026 Bitmine has 3,334,637 staked ETH, representing $7.1 billion at $2,123 per ETH MAVAN (Made in...
Ridgetech, Inc. Announces 1-for-150 Reverse Share Split
HANGZHOU, China, April 4, 2026 /PRNewswire/ -- Ridgetech, Inc., a Cayman Islands exempted company (the "Company") (Nasdaq: RDGT), a wholesale distributor of pharmaceutical and other healthcare products in China, today announced that it expects to...
Syneron Bio Announces Completion of $150 Million Series B Financing
BEIJING, April 3, 2026 /PRNewswire/ -- Syneron Bio, a leader in intelligent platform-driven macrocyclic peptide drug discovery, announced the successful closing of its Series B financing on March 31th. The round was led by an international...
Vastnaut One: Designed for Outdoor Explorers to Push Beyond Boundary
Vastnaut Announces Official Pre-Order of the Vastnaut One AI-Powered 4x4 Exoskeleton LOS ANGELES, April 2, 2026 /PRNewswire/ -- Vastnaut has officially unveiled the Vastnaut One - the world's first AI-powered 4 Joints x 4 Motors exoskeleton....